October 22, 2016 7:55 PM ET


Company Overview of Axovant Sciences Ltd.

Key Executives for Axovant Sciences Ltd.

NameBoard RelationshipsTitleAge
Vivek Ramaswamy 16 RelationshipsChief Executive Officer and Director30
Mark Altmeyer MBA5 RelationshipsPresident and Chief Commercial Officer55
Gregory M. Weinhoff M.D., MBA26 RelationshipsChief Financial Officer45
Marianne L. Romeo Dinsmore 6 RelationshipsHead of Global Transactions & Risk Management and Director48

Axovant Sciences Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Vivek Ramaswamy 16 RelationshipsAxovant Sciences Ltd.30
Marianne L. Romeo Dinsmore 6 RelationshipsAxovant Sciences Ltd.48
Berndt A. E. Modig MBA, CPA 40 RelationshipsBioMarin Nederland B.V.57
Ilan Oren B.A. 17 RelationshipsDexcel Ltd.32
Atul C. Pande M.D. 98 RelationshipsTal Medical Inc.61
View All Board Members

Axovant Sciences Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee MBA, CPABerndt A. E. Modig40 Relationships3 Executives
Compensation Committee B.A.Ilan Oren17 Relationships3 Executives
Nominating Committee M.D.Atul C. Pande98 Relationships3 Executives
Corporate Governance Committee M.D.Atul C. Pande98 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$350.0K
Total Value of Options
Compensation as of Fiscal Year
Axovant Sciences Ltd. CEO Compensation
Industry Average


4SC AG Announces Executive Changes
October 21, 2016 9:18 AM ET
Rosetta Genomics Ltd. Appoints Mark R. Willig as Chief Commercial Officer
October 20, 2016 12:40 PM ET
ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors
October 20, 2016 12:30 PM ET
Proteon Therapeutics Inc. Appoints Paul J. Hastings as Chairman of Board of Directors
October 20, 2016 12:00 PM ET
Vaxil Bio Ltd. Announces Executive Changes
October 20, 2016 11:12 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Axovant Sciences Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.